← Leaderboards
John R Asplin
Litholink Corporation
$1,286,570
Attributed
$1,286,570
Total exposure
5
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $255.8K · FY2005–07$500K$375K$250K$125K$0
'05
'06
'07
Funding mix
By agency
NIH$1,286,570 · 5
By mechanism
R44$1,005,630 · 2
R43$280,940 · 3
Top collaborators
No co-investigators on record.
Most similar at Litholink Corporation
Same institution · by research overlap
- Kristin J Bergsland$3,024,110
Others in their field
Top investigators on “Hypercalciuria”
- Laura M Hales · Extend Biosciences, Inc.$9,036,767
- John C Lieske · University Of Chicago$4,989,538
- David A Bushinsky · University Of Rochester$4,181,329
- Harald W. Jueppner · Massachusetts General Hospital$3,855,049
- Michael A Levine · Children'S Hosp Of Philadelphia$3,436,963
- Shonni J Silverberg · Columbia University Health Sciences$3,135,231
Research focus
HypercalciuriaDisease /Disorder Proneness /RiskNephrolithiasisClinical ResearchNephrocalcinosisHuman Population StudyOsteoporosisHuman SubjectArtificial IntelligencePhoton AbsorptiometryComputer System Design /EvaluationComputer Program /SoftwareBone DensityMathematical ModelCalculiCalcium PhosphateBiologyCalcium Oxalate Crystal Growth InhibitorCollectionCalcium OxalateBikuninCohortCalciumCitrates
Grant awards (6)
Urine Crystal Inhibition in Pediatric Nephrolithiasis$255,827
R44 · FY2007 · DK · contact PI
Treatment of Calcium Nephrolithiasis Sodium Thiosulfate$164,683
R43 · FY2006 · DK · contact PI
Urine Protein Predictors of Nephrolithiasis$16,257
R43 · FY2005 · DK
Osteoporosis in Hypercalciuric Kidney Stone Formers$357,180
R44 · FY2003 · DK
Osteoporosis in Hypercalciuric Kidney Stone Formers$392,623
R44 · FY2002 · DK
OSTEOPOROSIS IN HYPERCALCURIC KIDNEY STONE FORMERS$100,000
R43 · FY2001 · DK